Heron Therapeutics: Q2 Earnings Snapshot

August 9, 2022 GMT

SAN DIEGO (AP) _ Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $56.4 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 55 cents.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.

The pharmaceutical company posted revenue of $27.6 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX